Completed PHASE1/PHASE2 INTERVENTIONAL NCT00232778

A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)

Sponsor: Cordis US Corp.

Interventions GAMMA-Iridium-192 catheter

Updated 7 times since 2017 Last updated: Apr 17, 2008 Started: May 31, 2000 Completion: Jun 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00232778, this PHASE1/PHASE2 trial focuses on Coronary Artery Disease and remains completed. Sponsored by Cordis US Corp., it has been updated 7 times since 2000, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Dec 2025 — Present [monthly]

Completed PHASE1/PHASE2
Sep 2024 — Dec 2025 [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1_PHASE2

First recorded

May 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cordis US Corp.

Data source: Cordis US Corp.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.